Endocannabinoid signals in the developmental programming of delayed-onset neuropsychiatric and metabolic illnesses

Biochemical Society Transactions

Volumn 41, Issue 6, 2013, Pages 1569-1576

  Keimpema, Erik ^a   Calvigioni, Daniela ^a   Harkany, Tibor ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Medical University of Vienna   (Austria)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adolescence; Cannabis; Fetal development; Metabolism; Obesity; Translational Neuroscience

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA INTERMEDIN; CANNABIS; CHOLECYSTOKININ; DOPAMINE 2 RECEPTOR; ENDOCANNABINOID; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; PARVALBUMIN;

ADIPOSE TISSUE; BRAIN DEVELOPMENT; CANNABIS ADDICTION; COGNITIVE DEFECT; CONFERENCE PAPER; DIABETES MELLITUS; DRUG USE; EMBRYO DEVELOPMENT; EPILEPSY; FETUS DEVELOPMENT; HIPPOCAMPUS; HISTOGENESIS; HUMAN; HYPOTHALAMUS; INFECTION; MALNUTRITION; MATERNAL NUTRITION; MATERNAL OBESITY; MENTAL DISEASE; METABOLIC DISORDER; METABOLISM; MOLECULAR PATHOLOGY; NERVOUS TISSUE; NEUROTRANSMISSION; NONHUMAN; ORGANOGENESIS; PLACENTA; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PSYCHOSIS; PUERPERAL DEPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

AGE OF ONSET; ANIMALS; ENDOCANNABINOIDS; HUMANS; MENTAL DISORDERS; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 84887897615     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130117     Document Type: Conference Paper

References (84)

1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, III edn, American Psychiatric Association, Washington, DC
2. Lyon, M., Barr, C.E., Cannon, T.D., Mednick, S.A. and Shore, D. (1989) Fetal neural development and schizophrenia. Schizophr. Bull. 15, 149-161
3. Blennow, K. and Zetterberg, H. (2013) The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease. Med. Clin. North Am. 97, 369-376
4. Teipel, S.J., Sabri, O., Grothe, M., Barthel, H., Prvulovic, D., Buerger, K., Bokde, A.L., Ewers, M., Hoffmann, W. and Hampel, H. (2013) Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease. J. Alzheimer's Dis. 33 (Suppl. 1), S329-S347
5. Teipel, S.J., Grothe, M., Lista, S., Toschi, N., Garaci, F.G. and Hampel, H. (2013) Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med. Clin. North Am. 97, 399-424
6. Simopoulos, A.P. (2002) The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 56, 365-379
7. Reilly, J.J., Armstrong, J., Dorosty, A.R., Emmett, P.M., Ness, A., Rogers, I., Steer, C. and Sherriff, A. (2005) Early life risk factors for obesity in childhood: cohort study. BMJ 330, 1357
8. Bayol, S.A., Farrington, S.J. and Stickland, N.C. (2007) A maternal 'junk food' diet in pregnancy and lactation promotes an exacerbated taste for 'junk food' and a greater propensity for obesity in rat offspring. Br. J. Nutr. 98, 843-851
9. Casas, M., Chatzi, L., Carsin, A.E., Amiano, P., Guxens, M., Kogevinas, M., Koutra, K., Lertxundi, N., Murcia, M., Rebagliato, M. et al. (2013) Maternal pre-pregnancy overweight and obesity, and child neuropsychological development: two Southern European birth cohort studies. Int. J. Epidemiol. 42, 506-517
10. Ross, M.G., Desai, M., Khorram, O., McKnight, R.A., Lane, R.H. and Torday, J. (2007) Gestational programming of offspring obesity: a potential contributor to Alzheimer's disease. Curr. Alzheimer Res. 4, 213-217
11. Krakowiak, P., Walker, C.K., Bremer, A.A., Baker, A.S., Ozonoff, S., Hansen, R.L. and Hertz-Picciotto, I. (2012) Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129, e1121-e1128
12. Zimmerman, A.W. and Connors, S.L. (2010) Maternal Influences on Fetal Neurodevelopment: Clinical and Research Aspects, Springer, Berlin
13. Breton, C. (2013) The hypothalamus-adipose axis is a key target of developmental programming by maternal nutritional manipulation. J. Endocrinol. 216, R19-R31
14. Cupul-Uicab, L.A., Baird, D.D., Skjaerven, R., Saha-Chaudhuri, P., Haug, K. and Longnecker, M.P. (2011) In utero exposure to maternal smoking and women's risk of fetal loss in the Norwegian Mother and Child Cohort (MoBa). Hum. Reprod. 26, 458-465
15. Bell, S.H., Stade, B., Reynolds, J.N., Rasmussen, C., Andrew, G., Hwang, P.A. and Carlen, P.L. (2010) The remarkably high prevalence of epilepsy and seizure history in fetal alcohol spectrum disorders. Alcohol Clin. Exp. Res. 34, 1084-1089
16. Bale, J.F. (2009) Fetal infections and brain development. Clin. Perinatol. 36, 639-653
17. El Marroun, H., Hudziak, J.J., Tiemeier, H., Creemers, H., Steegers, E.A., Jaddoe, V.W., Hofman, A., Verhulst, F.C., van den Brink, W. and Huizink, A.C. (2011) Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 118, 470-474
18. Di Marzo, V. (2011) Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat. Neurosci. 14, 9-15
19. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. and Watanabe, M. (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309-380
20. Stella, N., Schweitzer, P. and Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778
21. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
22. Lutz, B. (2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. 68, 1691-1698
23. Jung, K.M., Astarita, G., Thongkham, D. and Piomelli, D. (2011) Diacylglycerol lipase-α and -β control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms. Mol. Pharmacol. 80, 60-67
24. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M.G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.J. et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463-468
25. Simon, G.M. and Cravatt, B.F. (2010) Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo. Mol. Biosyst. 6, 1411-1418
26. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S. and Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A. 99, 10819-10824
27. Devane, W.A., Dysarz, III, F.A., Johnson, M.R., Melvin, L.S. and Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613
28. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564
29. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65
30. Brown, A.J. (2007) Novel cannabinoid receptors. Br. J. Pharmacol. 152, 567-575
31. Ross, R.A. (2003) Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801
32. Wilson, R.I. and Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592
33. Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M. and Galve-Roperh, I. (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19, 1704-1706
34. Mulder, J., Aguado, T., Keimpema, E., Barabas, K., Ballester Rosado, C.J., Nguyen, L., Monory, K., Marsicano, G., Di Marzo, V., Hurd, Y.L. et al. (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl. Acad. Sci. U.S.A. 105, 8760-8765
35. Keimpema, E., Barabas, K., Morozov, Y.M., Tortoriello, G., Torii, M., Cameron, G., Yanagawa, Y., Watanabe, M., Mackie, K. and Harkany, T. (2010) Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J. Neurosci. 30, 13992-14007
36. Maison, P., Walker, D.J., Walsh, F.S., Williams, G. and Doherty, P. (2009) BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci. Lett. 467, 90-94
37. Keimpema, E., Tortoriello, G., Alpar, A., Capsoni, S., Arisi, I., Calvigioni, D., Hu, S.S., Cattaneo, A., Doherty, P., Mackie, K. and Harkany, T. (2013) Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 110, 1935-1940
38. Wu, C.S., Zhu, J., Wager-Miller, J., Wang, S., O'Leary, D., Monory, K., Lutz, B., Mackie, K. and Lu, H.C. (2010) Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur. J. Neurosci. 32, 693-706
39. Keimpema, E., Mackie, K. and Harkany, T. (2011) Molecular model of cannabis sensitivity in developing neuronal circuits. Trends Pharmacol. Sci. 32, 551-561
40. Hsiao, E.Y. and Patterson, P.H. (2012) Placental regulation of maternal-fetal interactions and brain development. Dev. Neurobiol. 72, 1317-1326
41. Helliwell, R.J., Chamley, L.W., Blake-Palmer, K., Mitchell, M.D., Wu, J., Kearn, C.S. and Glass, M. (2004) Characterization of the endocannabinoid system in early human pregnancy. J. Clin. Endocrinol. Metab. 89, 5168-5174
42. Herrera, E. and Ortega-Senovilla, H. (2010) Maternal lipid metabolism during normal pregnancy and its implication in fetal development. Clin. Lipidol. 5, 899-911
43. D'Asti, E., Long, H., Tremblay-Mercier, J., Grajzer, M., Cunnane, S.C., Di Marzo, V. and Walker, C.D. (2010) Maternal dietary fat determines metabolic profile and the magnitude of endocannabinoid inhibition of the stress response in neonatal rat offspring. Endocrinology 151, 1685-1694
44. Baskin, D.G., Blevins, J.E. and Schwartz, M.W. (2001) How the brain regulates food intake and body weight: the role of leptin. J. Pediatr. Endocrinol. Metab 14 (Suppl. 6), 1417-1429
45. Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T. and Kunos, G. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825
46. Walker, C.D., Naef, L., D'Asti, E., Long, H., Xu, Z., Moreau, A. and Azeddine, B. (2008) Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin. Ann. N.Y. Acad. Sci. 1144, 189-202
47. Muhlhausler, B.S., Adam, C.L., Findlay, P.A., Duffield, J.A. and McMillen, I.C. (2006) Increased maternal nutrition alters development of the appetite-regulating network in the brain. FASEB J. 20, 1257-1259
48. Bouret, S.G., Draper, S.J. and Simerly, R.B. (2004) Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J. Neurosci. 24, 2797-2805
49. Bouyer, K. and Simerly, R.B. (2013) Neonatal leptin exposure specifies innervation of presympathetic hypothalamic neurons and improves the metabolic status of leptin-deficient mice. J. Neurosci. 33, 840-851
50. Massa, F., Mancini, G., Schmidt, H., Steindel, F., Mackie, K., Angioni, C., Oliet, S.H., Geisslinger, G. and Lutz, B. (2010) Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. J. Neurosci. 30, 6273-6281
51. Udagawa, J., Hatta, T., Naora, H. and Otani, H. (2000) Expression of the long form of leptin receptor (Ob-Rb) mRNA in the brain of mouse embryos and newborn mice. Brain Res. 868, 251-258
52. McMillen, I.C., Edwards, L.J., Duffield, J. and Muhlhausler, B.S. (2006) Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity. Reproduction 131, 415-427
53. Smith, J.T. and Waddell, B.J. (2003) Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology 144, 3024-3030
54. Sugiura, T., Kobayashi, Y., Oka, S. and Waku, K. (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins, Leukotrienes Essent. Fatty Acids 66, 173-192
55. Chang, G.Q., Gaysinskaya, V., Karatayev, O. and Leibowitz, S.F. (2008) Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J. Neurosci. 28, 12107-12119
56. Begbie, J., Doherty, P. and Graham, A. (2004) Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo. J. Anat. 205, 213-218
57. Berghuis, P., Dobszay, M.B., Wang, X., Spano, S., Ledda, F., Sousa, K.M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G. et al. (2005) Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl. Acad. Sci. U.S.A. 102, 19115-19120
58. Morozov, Y.M., Torii, M. and Rakic, P. (2009) Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb. Cortex 19 (Suppl. 1), i78-i89
59. Berghuis, P., Rajnicek, A.M., Morozov, Y.M., Ross, R.A., Mulder, J., Urban, G.M., Monory, K., Marsicano, G., Matteoli, M., Canty, A. et al. (2007) Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316, 1212-1216
60. Kawaguchi, K., Habara, T., Terashima, T. and Kikkawa, S. (2010) GABA modulates development of cerebellar Purkinje cell dendrites under control of endocannabinoid signaling. J. Neurochem. 114, 627-638
61. Cristino, L., Busetto, G., Imperatore, R., Ferrandino, I., Palomba, L., Silvestri, C., Petrosino, S., Orlando, P., Bentivoglio, M., Mackie, K. and Di Marzo, V. (2013) Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 110, 2229-2238
62. Hurd, Y.L., Wang, X., Anderson, V., Beck, O., Minkoff, H. and Dow-Edwards, D. (2005) Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol. Teratol. 27, 221-229
63. Fried, P.A., Watkinson, B. and Gray, R. (2003) Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 25, 427-436
64. Dinieri, J.A., Wang, X., Szutorisz, H., Spano, S.M., Kaur, J., Casaccia, P., Dow-Edwards, D. and Hurd, Y.L. (2011) Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry 70, 763-769
65. Klausberger, T. and Somogyi, P. (2008) Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53-57
66. Leweke, F.M., Giuffrida, A., Wurster, U., Emrich, H.M. and Piomelli, D. (1999) Elevated endogenous cannabinoids in schizophrenia. NeuroReport 10, 1665-1669
67. Bernard, C., Milh, M., Morozov, Y.M., Ben Ari, Y., Freund, T.F. and Gozlan, H. (2005) Altering cannabinoid signaling during development disrupts neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 102, 9388-9393
68. Ben-Ari, Y. (2002) Excitatory actions of GABA during development: the nature of the nurture. Nat. Rev. Neurosci. 3, 728-739
69. Hensch, T.K. (2005) Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 6, 877-888
70. Lewis, D.A., Curley, A.A., Glausier, J.R. and Volk, D.W. (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35, 57-67
71. Volk, D.W., Eggan, S.M. and Lewis, D.A. (2010) Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am. J. Psychiatry 167, 1489-1498
72. Fitzgerald, M.L., Lupica, C.R. and Pickel, V.M. (2011) Decreased parvalbumin immunoreactivity in the cortex and striatum of mice lacking the CB1 receptor. Synapse 65, 827-831
73. Tricoire, L., Pelkey, K.A., Erkkila, B.E., Jeffries, B.W., Yuan, X. and McBain, C.J. (2011) A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. J. Neurosci. 31, 10948-10970
74. Semple, D.M., McIntosh, A.M. and Lawrie, S.M. (2005) Cannabis as a risk factor for psychosis: systematic review. J. Psychopharmacol. 19, 187-194
75. D'Souza, D.C., Abi-Saab, W.M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T.B. and Krystal, J.H. (2005) δ-9-Tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 57, 594-608
76. Clark, P.A., Capuzzi, K. and Fick, C. (2011) Medical marijuana: medical necessity versus political agenda. Med. Sci. Monit. 17, RA249-RA261
77. Williams, C.M. and Kirkham, T.C. (1999) Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143, 315-317
78. Kirkham, T.C., Williams, C.M., Fezza, F. and Di, M. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136, 550-557
79. Jamshidi, N. and Taylor, D.A. (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 134, 1151-1154
80. Quarta, C., Bellocchio, L., Mancini, G., Mazza, R., Cervino, C., Braulke, L.J., Fekete, C., Latorre, R., Nanni, C., Bucci, M. et al. (2010) CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab. 11, 273-285
81. Ravinet, T.C., Delgorge, C., Menet, C., Arnone, M. and Soubrie, P. (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 28, 640-648
82. Benoit, S.C., Tracy, A.L., Davis, J.F., Choi, D. and Clegg, D.J. (2008) Novel functions of orexigenic hypothalamic peptides: from genes to behavior. Nutrition 24, 843-847
83. Keimpema, E., Alpar, A., Howell, F., Malenczyk, K., Hobbs, C., Hurd, Y.L., Watanabe, M., Sakimura, K., Kano, M., Doherty, P. and Harkany, T. (2013) Diacylglycerol lipase α manipulation reveals developmental roles for intercellular endocannabinoid signaling. Sci. Rep. 3, 2093
84. Tanimura, A., Uchigashima, M., Yamazaki, M., Uesaka, N., Mikuni, T., Abe, M., Hashimoto, K., Watanabe, M., Sakimura, K. and Kano, M. (2012) Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc. Natl. Acad. Sci. U.S.A. 109, 12195-12200